| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9137597 | Blood Cells, Molecules, and Diseases | 2005 | 9 Pages |
Abstract
This increase on the activity of the acid β-glucosidase would imply that Miglustat is not only a substrate reducer but also an inhibitor of the GC degradation, with very promising clinical implications for the treatment of GD patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Biology
Authors
Pilar Alfonso, Sandra PampÃn, Jorge Estrada, José Carlos RodrÃguez-Rey, Pilar Giraldo, Javier Sancho, Miguel PocovÃ,